Screening for participants in the ISCHEMIA trial: Implications for clinical research. Journal of clinical and translational science Rodriguez, F., Hochman, J. S., Xu, Y., Reynolds, H. R., Berger, J. S., Mavromichalis, S., Newman, J. D., Bangalore, S., Maron, D. J. 2022; 6 (1): e90


The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) found that there was no statistical difference in cardiovascular events with an initial invasive strategy as compared with an initial conservative strategy of guideline-directed medical therapy for patients with moderate to severe ischemia on noninvasive testing. In this study, we describe the reasons that potentially eligible patients who were screened for participation in the ISCHEMIA trial did not advance to enrollment, the step prior to randomization. Of those who preliminarily met clinical inclusion criteria on screening logs submitted during the enrollment period, over half did not participate due to physician or patient refusal, a potentially modifiable barrier. This analysis highlights the importance of physician equipoise when advising patients about participation in randomized controlled trials.

View details for DOI 10.1017/cts.2022.428

View details for PubMedID 36003207

View details for PubMedCentralID PMC9389278